glp-1 clinical trials RAs: summary of head-to-head Mapping the effectiveness and risks

For a detailed comparison, see our Retatrutide vs Tirzepatide Comparison and the three-compound comparison guide

Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia

This distinguishes it from better-known compounds such as semaglutide (Ozempic/Wegovy), which targets only the GLP-1 receptor, and from tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP agonist

Cell Host Microbe 16 , 795805 (2014)

The results indicate that GLP-1RAs improve neurodegenerative conditions through several mechanisms, such as decreasing inflammation, enhancing neuroprotection, and boosting cognitive performance

We are familiar with the studies suggesting that B12 supplementation may improve physical performance, particularly in those with low B12 levels